Late detection often requires major surgeries, such as bladder removal followed by artificial bladder implantation or the use of a urine pouch, significantly lowering the patient's quality of life.

An artificial intelligence platform may help identify BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC) and steer alternative treatment.